​

P3 Health Partners (PIII) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PIII Stock Rating

P3 Health Partners stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

PIII Price Target Upside V Benchmarks

TypeNameUpside
StockP3 Health Partners-
SectorHealthcare Stocks 24.81%
IndustryMedical Care Facilities Stocks14.62%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$6.35$6.35$6.35
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-22--4
May, 25-22--4
Apr, 25-22--4
Mar, 25-22--4
Feb, 25-22--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 01, 2024BTIGNeutraldowngrade
Jan 12, 2023William BlairOutperformOutperformhold

Financial Forecast

EPS Forecast

$-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.24$-6.50$-0.61$-2.08--
Avg Forecast$-0.77$-5.14$-0.74$-0.56$-0.40$-0.42
High Forecast$-0.75$-4.85$-0.68$-0.52$-0.37$-0.39
Low Forecast$-0.79$-5.47$-0.81$-0.61$-0.44$-0.46
Surprise %-68.83%26.46%-17.57%271.43%--

Revenue Forecast

$0 $100B $200B $300B $400B $500B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$491.06B$1.05B$1.27B$1.50B--
Avg Forecast$642.00M$1.04B$1.22B$1.51B$1.49B$1.67B
High Forecast$653.98M$1.10B$1.31B$1.52B$1.52B$1.79B
Low Forecast$629.60M$998.86M$1.21B$1.42B$1.46B$1.57B
Surprise %76389.65%0.51%3.56%-0.50%--

Net Income Forecast

$-2B $-2B $-1B $-800M $-400M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-10.08M$-270.13M$-57.77M$-301.60M--
Avg Forecast$-226.83M$-1.51B$-219.59M$-166.17M$-118.25M$-124.58M
High Forecast$-221.14M$-1.43B$-200.73M$-151.90M$-108.09M$-113.88M
Low Forecast$-232.34M$-1.61B$-238.45M$-180.45M$-128.41M$-135.28M
Surprise %-95.56%-82.15%-73.69%81.50%--

PIII Forecast FAQ

Is P3 Health Partners stock a buy?

P3 Health Partners stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that P3 Health Partners is a favorable investment for most analysts.

What is P3 Health Partners's price target?

P3 Health Partners's price target, set by 4 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $6.35.

How does P3 Health Partners stock forecast compare to its benchmarks?

P3 Health Partners's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the medical care facilities stocks industry (14.62%).

What is the breakdown of analyst ratings for P3 Health Partners over the past three months?

  • June 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is P3 Health Partners’s EPS forecast?

P3 Health Partners's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.4, marking a -80.77% decrease from the reported $-2.08 in 2024. Estimates for the following years are.

What is P3 Health Partners’s revenue forecast?

P3 Health Partners's average annual revenue forecast for its fiscal year ending in December 2025 is $1.49B, reflecting a -0.67% decrease from the reported $1.5B in 2024. The forecast for.

What is P3 Health Partners’s net income forecast?

P3 Health Partners's net income forecast for the fiscal year ending in December 2025 stands at $-118M, representing a -60.79% decrease from the reported $-302M in 2024. Projections indicate .